GOSS · Gossamer Bio Inc
United States · RS rating 92 · As of 2026-10-14
| Price | 8.90 USD |
|---|---|
| 1-day change | -8.8% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 17 / 99 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 29 / 38 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +3.8% |
| Distance from 52-week high | +25.4% |
| Market cap (USD) | $87.7M |